Release Date: 11/07/16 18:52 Summary: Change in substantial holding-BRB.AX Price Sensitive: No Download Document 206.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%